MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Amcal Osteo Relief Paracetamol | |
New | AndroFeme 1 | |
New | APOHealth Infant Saline Nasal Drops with Aspirator | |
New | APOHealth Laxative with Softener | |
New | APOHealth Period Pain Relief | |
New | APOHealth Saline Nasal Spray | |
New | APO-Lurasidone | |
New | APX-Paracetamol/Codeine | |
New | Atectura Breezhaler | |
New | ATO Lidocaine | |
New | Blooms the Chemist Sleep Assist | |
New | Cefuroxime SXP | |
New | Chemists' Own Osteo Relief Paracetamol | |
New | Chemists' Own Osteo Relief Paracetamol Bottle | |
New | Comirnaty | |
New | COVID-19 Vaccine AstraZeneca | |
New | Daptomycin Accord | |
New | Daptomycin Juno | |
New | Finomel | |
New | Isotretinoin GX | |
New | Jorveza | |
New | Medco Ibuprofen 200 and Codeine Phosphate 12.8 | |
New | Medco Paracetamol 500 and Codeine Phosphate 15 | |
New | Medsurge Alfentanil | |
New | Noumed Amoxicillin Powder for Suspension | |
New | Noumed Diazepam | |
New | Noumed Esomeprazole | |
New | Oseltamivir Lupin | |
New | Oxycodone HCl Medsurge | |
New | Pemetrexed-AFT | |
New | Pharmacor Letrozole 2.5 | |
New | Pharmacor Posaconazole | |
New | Pharmacy Choice Osteo Relief Paracetamol | |
New | Prasugrel SCP | |
New | Pryzex (New Formulation) | |
New | Quetiapine Sandoz Pharma | |
New | Rabeprazole Mylan | |
New | Rosken Skin Repair | |
New | Sildenafil PHT APOTEX | |
New | Solifenacin Lupin | |
New | Spironolactone Mylan | |
New | Trientine Waymade | |
New | Vizo-PF Bimatoprost | |
New | Xorox | |
New | Zeposia | |
Reinstated | APOHealth Osteo Relief Paracetamol | |
Reinstated | Oxycodone Mylan | |
Revised | Acetadote Concentrated Injection | TGA Date |
Revised | Aczone | TGA Date |
Revised | Afluria Quad | Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Air Liquide Australia Limited Nitronox | Nature and Contents of Container, Special Precautions for Storage |
Revised | Allmercap | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Alphagan | Product Name change |
Revised | Alphagan P 1.5 | Product Name change |
Revised | Anthelios Sunscreens | New Presentation of Brand already available |
Revised | APO-Exemestane | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | APO-Fluconazole One | Interactions with Other Medicines and Other Forms of Interactions |
Revised | APO-Fluvoxamine | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Metformin | TGA Date |
Revised | APO-Mirtazapine | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Tramadol | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, New contraindication, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | APO-Zolpidem | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Zopiclone Tablets | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Arcoxia | Sponsor |
Revised | Arsenic Trioxide Juno | TGA Date |
Revised | Atacand | TGA Date |
Revised | Atacand Plus | TGA Date |
Revised | Atorvachol | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Atozet | Sponsor |
Revised | Avanza | Sponsor |
Revised | Avapro HCT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Axotide | New contraindication |
Revised | Azopt | List of Excipients, Nature and Contents of Container |
Revised | B. Braun Gentamicin | Adverse Effects (Undesirable Effects), Incompatibilities, Special Warnings and Precautions for Use |
Revised | Baxter Water for Injections BP | Physicochemical Properties |
Revised | Berinert SC | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Betoptic | Deleted Presentation |
Revised | Betoquin | Nature and Contents of Container, Physicochemical Properties |
Revised | Bicillin L-A | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Brevibloc | Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Bridion | Pharmacological Properties |
Revised | BrinzoQuin | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Briviact | Shelf Life |
Revised | Briviact Solution for Injection | Shelf Life |
Revised | Budamax | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Bupredermal | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Buprenorphine Sandoz | Adverse Effects (Undesirable Effects), Boxed Warnings, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, New indication, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Catapres 100 | Pharmaceutical Form, Sponsor |
Revised | Catapres 150 Tablets and Catapres Ampoules | Pharmaceutical Form, Sponsor |
Revised | Celestone Chronodose | Sponsor |
Revised | Chemists' Own Anti-Inflammatory Pain Relief 25 Liquid Capsules | TGA Date |
Revised | Chlorsig | Dose and Method of Administration |
Revised | Ciloquin | TGA Date |
Revised | Ciloquin Ear Drops | TGA Date |
Revised | Ciloxan | TGA Date |
Revised | Ciloxan Ear Drops | TGA Date |
Revised | Cipramil | TGA Date |
Revised | Circadin | Nature and Contents of Container |
Revised | Citalopram Sandoz | Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Overdose, Special Warnings and Precautions for Use |
Revised | Clomid | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Combigan | TGA Date |
Revised | Comtan | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Sponsor |
Revised | Copaxone Prefilled Syringe | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | DBL Potassium Phosphate - Monobasic and Potassium Phosphate - Dibasic | TGA Date |
Revised | Depo-Medrol | Dose and Method of Administration, Pharmaceutical Form, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Depo-Nisolone | Dose and Method of Administration, Pharmaceutical Form, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Descovy | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Diane-35 ED | Contraindications, Special Warnings and Precautions for Use |
Revised | Diflucan One | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Dizole | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Duloxecor | Fertility, Pregnancy and Lactation |
Revised | Elaprase | Fertility, Pregnancy and Lactation, Overdose, Qualitative and Quantitative Composition |
Revised | Eldepryl | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Endoxan | TGA Date |
Revised | Enidin | TGA Date |
Revised | Eraxis | Dose and Method of Administration, Shelf Life, Special Precautions for Storage |
Revised | Ertapenem Juno | TGA Date |
Revised | Esmeron | Adverse Effects (Undesirable Effects) |
Revised | Esomeprazole RBX | Nature and Contents of Container |
Revised | Evelyn 150/30 ED | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, New contraindication, Overdose, Pharmacological Properties |
Revised | Ezetrol | Sponsor |
Revised | Faverin | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Finasteride-1mg | Sponsor |
Revised | Firazyr | TGA Date |
Revised | Flixotide | New contraindication |
Revised | Fluad Quad | List of Excipients, Pharmaceutical Form, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage |
Revised | Fluconazole Sandoz | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Fluconazole Sandoz Injection | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Fosamax Plus | Sponsor |
Revised | Ganfort PF 0.3/5 | Nature and Contents of Container |
Revised | Genoptic | Physicochemical Properties |
Revised | Herzuma | TGA Date |
Revised | Humulin Preparations | Adverse Effects (Undesirable Effects), Dose and Method of Administration, List of Excipients, Special Warnings and Precautions for Use |
Revised | Hydrea | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ibavyr | Nature and Contents of Container, Pharmacological Properties |
Revised | Ibudeine | Boxed Warnings, Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Imatinib GH | TGA Date |
Revised | Implanon NXT | Special Warnings and Precautions for Use, Sponsor |
Revised | Iressa | Adverse Effects (Undesirable Effects) |
Revised | Jakavi | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Jevtana | List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties |
Revised | Kalma | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Karvezide | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Kenalog in Orabase | Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties |
Revised | Lercanidipine Apotex | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Lescol XL | TGA Date |
Revised | Lignospan Special | TGA Date |
Revised | Livial | Sponsor |
Revised | Lomide Eye Drops | TGA Date |
Revised | Lurasidone Lupin | Shelf Life |
Revised | Marvelon 28 | TGA Date |
Revised | Mavenclad | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Maxalt | Sponsor |
Revised | MDP | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Shelf Life, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Mekinist | Adverse Effects (Undesirable Effects) |
Revised | Milrinone GH | Adverse Effects (Undesirable Effects), Contraindications, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Minims Phenylephrine Hydrochloride Eye Drops | Special Warnings and Precautions for Use |
Revised | Miostat | TGA Date |
Revised | Mirtanza | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Mirtanza ODT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Movapo | TGA Date |
Revised | Movapo PFS | TGA Date |
Revised | Mycamine | TGA Date |
Revised | Neurontin | Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Nizac | TGA Date |
Revised | Norflex | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Norspan | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Noumed Lansoprazole | New Brand of Product already available |
Revised | NuvaRing | Sponsor |
Revised | Octagam 10% | TGA Date |
Revised | Octagam 5% | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Ofev | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Olmekar HCT | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Olmesartan HCT-MYL | Sponsor |
Revised | Olmesartan/ Amlodipine - MYL | Sponsor |
Revised | Olmesartan-MYL | Sponsor |
Revised | Olmetec | Sponsor |
Revised | Olmetec Plus | Sponsor |
Revised | Onkotrone | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Osmitrol Intravenous Infusion | TGA Date |
Revised | OxyContin | Pharmacological Properties |
Revised | OxyNorm | Pharmacological Properties |
Revised | OxyNorm Injection | Pharmacological Properties |
Revised | Paclitaxel Ebewe | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Panadol (Children) 3+ Years Chewable Tablets | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, TGA Date |
Revised | Panadol (Children) 7+ Years Soluble Tablets | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, TGA Date |
Revised | Panadol (Children) Liquid Formulations | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, TGA Date |
Revised | Panadol (Children) Suppositories | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, TGA Date |
Revised | Patanol | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Paxtine | Effects on Ability to Drive and Use Machines, Physicochemical Properties |
Revised | Persantin Ampoules | Sponsor, TGA Date |
Revised | Piramal Sevoflurane | Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Plavix | Nature and Contents of Container, Pharmaceutical Form |
Revised | Plegridy | TGA Date |
Revised | Pregabalin Alphapharm | Nature and Contents of Container, Product Name change |
Revised | Pregabalin GH | Boxed Warnings, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Primoteston Depot | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Propecia | Sponsor |
Revised | Proscar | Sponsor |
Revised | Pryzex ODT | List of Excipients, Special Precautions for Storage |
Revised | Renflexis | TGA Date |
Revised | Renitec | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Renitec Plus 20/6 | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use, Sponsor |
Revised | Rhinocort Aqueous Nasal Spray | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, Product Name change, Special Warnings and Precautions for Use |
Revised | Rixubis | TGA Date |
Revised | Rizatriptan Wafers-10 mg | Sponsor |
Revised | Salofalk Enemas | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use, Sponsor |
Revised | Salofalk Foam | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Product Name change, Special Warnings and Precautions for Use, Sponsor |
Revised | Salofalk Granules | Adverse Effects (Undesirable Effects), List of Excipients, Special Warnings and Precautions for Use, Sponsor |
Revised | Salofalk Suppositories | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use, Sponsor |
Revised | Salofalk Tablets | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Sponsor |
Revised | Sandoz Ibuprofen Plus Codeine | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Saphris | Sponsor |
Revised | Scheriproct | Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Sevikar | Sponsor |
Revised | Sevikar HCT | Sponsor |
Revised | Signifor | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Sinemet CR | Sponsor |
Revised | Solu-Cortef | Pharmaceutical Form, Therapeutic Indications |
Revised | Somidem | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Spinraza | TGA Date |
Revised | Sulprix | Adverse Effects (Undesirable Effects) |
Revised | Suxamethonium Juno | TGA Date |
Revised | Tafinlar | Adverse Effects (Undesirable Effects) |
Revised | Tazac | TGA Date |
Revised | Tecfidera | Adverse Effects (Undesirable Effects) |
Revised | Teriflunomide GH | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Tobra-Day | Pharmaceutical Form, References, Shelf Life, Special Precautions for Storage |
Revised | Tremfya | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Trust Analgesic Calmative | Boxed Warnings, Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Valpam | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Varilrix HSA-Free | Dose and Method of Administration |
Revised | Veltassa | TGA Date |
Revised | Venclexta | Nature and Contents of Container |
Revised | Versatis | TGA Date |
Revised | Verzenio | Dose and Method of Administration |
Revised | Voriconazole Wockhardt | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Xylocaine 10% Pump Spray | TGA Date |
Revised | Xylocaine and Xylocaine with Adrenaline | TGA Date |
Revised | Xyvion | Sponsor |
Revised | Zient | Sponsor, TGA Date |
Revised | Ziextenzo | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zinforo | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zolpibell | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zolpidem Sandoz Pharma | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Deleted | Adronat | |
Deleted | AndroFeme 1 (WA) | |
Deleted | Auro-Famciclovir | |
Deleted | Auro-Lisinopril | |
Deleted | Auro-Sertraline | |
Deleted | Beprol | |
Deleted | Dimetapp PE Sinus Pain + Allergy Tablets | |
Deleted | Gallium (Ga67) Citrate Injection | |
Deleted | Hyforil | |
Deleted | Keflin Neutral | |
Deleted | Klyx | |
Deleted | Lamotrigine Sandoz | |
Deleted | Loxip | |
Deleted | Megace | |
Deleted | Ostira | |
Deleted | Rosken Skin Repair Cream | |
Deleted | Tenolten |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au